NO975862D0 - P-selektinligander og relaterte molekyler og fremgangsmåter - Google Patents

P-selektinligander og relaterte molekyler og fremgangsmåter

Info

Publication number
NO975862D0
NO975862D0 NO975862A NO975862A NO975862D0 NO 975862 D0 NO975862 D0 NO 975862D0 NO 975862 A NO975862 A NO 975862A NO 975862 A NO975862 A NO 975862A NO 975862 D0 NO975862 D0 NO 975862D0
Authority
NO
Norway
Prior art keywords
methods
related molecules
selectin ligands
selectin
ligands
Prior art date
Application number
NO975862A
Other languages
English (en)
Other versions
NO975862L (no
Inventor
Brian Seed
Tara Pouyani
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO975862D0 publication Critical patent/NO975862D0/no
Publication of NO975862L publication Critical patent/NO975862L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO975862A 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter NO975862L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21395P 1995-06-14 1995-06-14
PCT/US1996/010043 WO1997000079A1 (en) 1995-06-14 1996-06-11 P-selectin ligands and related molecules and methods

Publications (2)

Publication Number Publication Date
NO975862D0 true NO975862D0 (no) 1997-12-12
NO975862L NO975862L (no) 1998-02-12

Family

ID=21690430

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975862A NO975862L (no) 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter

Country Status (14)

Country Link
EP (1) EP0833650A4 (no)
JP (1) JPH11508131A (no)
KR (1) KR19990022954A (no)
AR (1) AR003436A1 (no)
AU (1) AU6272996A (no)
BR (1) BR9608918A (no)
CA (1) CA2224625A1 (no)
CZ (1) CZ401497A3 (no)
HU (1) HUP9901131A2 (no)
IL (1) IL122590A0 (no)
NO (1) NO975862L (no)
TR (1) TR199701620T1 (no)
WO (1) WO1997000079A1 (no)
ZA (1) ZA965032B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2975599A (en) * 1998-02-27 1999-09-15 Genetics Institute Inc. P-selectin ligand protein including tetrameric fusion proteins
EP1406930A4 (en) * 2000-12-29 2007-01-10 Savient Pharmaceuticals Inc "ISOLATED MOLECULES WITH SULFATED GROUPING CONTAINING EPITOPES, ANTIBODIES AGAINST SUCH EPITOPES AND USES THEREOF"
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2183851T3 (es) * 1990-07-17 2003-04-01 Univ Oklahoma Ligando de gmp-140.
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
AU681369B2 (en) * 1992-11-16 1997-08-28 Board Of Regents Of The University Of Oklahoma, The Glycoprotein ligand for P-selectin and methods of use thereof
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Also Published As

Publication number Publication date
JPH11508131A (ja) 1999-07-21
WO1997000079A1 (en) 1997-01-03
AU6272996A (en) 1997-01-15
IL122590A0 (en) 1998-06-15
BR9608918A (pt) 1999-06-15
KR19990022954A (ko) 1999-03-25
ZA965032B (en) 1997-03-14
HUP9901131A2 (hu) 1999-07-28
CA2224625A1 (en) 1997-01-03
EP0833650A4 (en) 2005-01-19
TR199701620T1 (xx) 1998-05-21
AR003436A1 (es) 1998-08-05
EP0833650A1 (en) 1998-04-08
CZ401497A3 (cs) 1998-07-15
NO975862L (no) 1998-02-12

Similar Documents

Publication Publication Date Title
DK1095941T3 (da) Fremgangsmåde og krystalformer for 2-methyl-thieno-benzodiazepin
NO973836L (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO20001307L (no) Cyklopentafenantreneyl-metallkomplekser og polymerisasjonsprosess
DK0959975T3 (da) Hidtil ukendte affinitetsligander og deres anvendelse
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
DK0863856T3 (da) Komposteringssystem og fremgangsmåde
DE69525695D1 (de) Objektbasiertes Anzeigesystem und Verfahren
KR970005038A (ko) 근경조식방법과 그 장치
DE69609534D1 (de) Rechnerbasierte 3D-Darstellungsverfahren und -System
DK0723967T3 (da) Organometalforbindelser og polymerer fremstillet deraf
DE69623396D1 (de) Geschmacksveränderungsmittel
DE69628248D1 (de) Graphenanzeigevorrichtungen und -verfahren
DE69604230D1 (de) Pumpeinheit und -verfahren
DE69628873D1 (de) Ausrichtgerät und -verfahren
DE69622942D1 (de) Flussigkristall-anzeigvorrichtung
DE69511704D1 (de) Dreidimensionales anzeigeverfahren und -gerät
DE59610777D1 (de) Absperreinrichtung
NO975862D0 (no) P-selektinligander og relaterte molekyler og fremgangsmåter
DK0780388T3 (da) 5HT1Dalfa og 5HT2A ligander
DK0752511T3 (da) Hængsel og hængselfastgørelse
KR970005166A (ko) 다리동작이 용이한 마네킹
KR970002716U (ko) 액정표시소자
BR9501603A (pt) Aperfeiçoamento introduzido em lacre
KR960029598U (ko) 조경 및 광고보드
BR7502539U (pt) Disposição introduzida em livro